ArticlePharmacoEconomics - open2019
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.
Article in PharmacoEconomics - open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Economic cost of end-stage renal disease in Africa: a systematic review.BMC nephrology · 2025Pooled it
- Effects of an Omaha system-based continuing nursing program on nutritional status in patients undergoing peritoneal dialysis: a randomized controlled trial.International urology and nephrology · 2020Trial
- Impact of pretransplant donor-specific antibodies and human leukocyte antigen mismatches on graft and patient outcomes: A cohort from Saudi Arabia.World journal of transplantation · 2026Article
- Hospital-based health technology assessment of central dialysis fluid delivery system for hemodialysis patients.BMC nephrology · 2025Article
- Lived Experiences of Patients Undergoing Hemodialysis in Selected Teaching Hospitals in Rwanda.Rwanda journal of medicine and health sciences · 2025Article
- Economic burden of end stage renal disease: a case study in southern Iran.Health economics review · 2025Article
- Cost-effectiveness and budget impact analysis of peritoneal dialysis and haemodialysis in South Africa.BMC health services research · 2025Article
- Challenges in Diagnosis and Management of SLE in Africa: An Online Survey.ACR open rheumatology · 2025Article
- Article
- The economic burden of hemodialysis and associated factors of among patients in private and public health facilities: a cross-sectional study in Addis Ababa, Ethiopia.Cost effectiveness and resource allocation : C/E · 2024Article
- Chronic diseases spectrum and multimorbidity in elderly inpatients based on a 12-year epidemiological survey in China.BMC public health · 2024Article
- Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria.Cost effectiveness and resource allocation : C/E · 2023Article
- Towards the Future of Public Health: Roadmapping Trends and Scenarios in the Post-COVID Healthcare Era.Healthcare (Basel, Switzerland) · 2023Article
- Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients' perspective at an Academic Hospital in Pretoria, South Africa.BMC health services research · 2023Article
- Article
- Article
- Factors affecting the quality of life for patients with end-stage renal disease on dialysis in KwaZulu-Natal province, South Africa: A descriptive survey.Health SA = SA Gesondheid · 2022Article
- Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care.Frontiers in pharmacology · 2021Article
- Retrospective Study on the Influencing Factors and Prediction of Hospitalization Expenses for Chronic Renal Failure in China Based on Random Forest and LASSO Regression.Frontiers in public health · 2021Article
- Long-term vascular access in differently resourced settings: a review of indications, devices, techniques, and complications.Pediatric surgery international · 2020Review
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHaemodialysis (HD) and peritoneal dialysis (PD) are commonly used treatments for the management of patients with end-stage renal disease (ESRD). The costs of managing these patients have grown in recent years with increasing rates of non-communicable diseases, which will adversely impact on national health budgets unless addressed. Currently, there is limited knowledge of the costs of ESRD within the public healthcare system in South Africa.
objectiveThe aim of this study was to examine the direct costs of HD and PD in South Africa from a healthcare provider's perspective.
methodsA prospective, observational study was undertaken at a leading public hospital in South Africa. A micro-costing approach was applied to estimate healthcare costs using 46 adult patients with ESRD who had been receiving HD and PD for at least 3 months.
resultsThe highest proportion of patients (35%) were aged 40-50 years. Patients aged 29-39 years were mostly on HD (28% vs. 21% on PD) while those aged 51-59 years mostly used PD (29% vs. 16% on HD). The average age of patients on HD and PD were 41 and 42 years, respectively. Fixed costs were the principal cost driver for HD ($16,231.45) while variable costs were the principal cost driver for PD (US$20,488.79). The annual cost of HD per patient (US$31,993.12) was higher than PD (US$25,282.00 per patient), even though the difference was not statistically significant (p = 0.816).
conclusionHD costs more than PD from the provider's perspective. These cost estimates may be useful for carrying out future cost-effectiveness and cost-utility analyses in South Africa.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.